Package Leaflet: Information for the User
Xyrem 500 mg/ml Oral Solution
Sodium Oxybate
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack and other information
Xyrem contains the active substance sodium oxybate. Xyrem works by consolidating nocturnal sleep, although its exact mechanism of action is not known.
Xyrem is used to treat narcolepsy with cataplexy in adults, adolescents, and children from 7 years of age.
Narcolepsy is a sleep disorder that can include sleep attacks during the hours when you are normally awake, as well as cataplexy, sleep paralysis, hallucinations, and insomnia. Cataplexy is the sudden appearance of weakness or muscle paralysis without loss of consciousness, in response to a sudden emotional reaction such as anger, fear, joy, laughter, or surprise.
Do not take Xyrem
Warnings and precautions
Talk to your doctor or pharmacist before you start taking Xyrem.
can involve hallucinations, incoherent speech, or disorganized and agitated behavior) or bipolar disorder;
If you have any of these problems, tell your doctor before taking Xyrem.
If, while taking Xyrem, you experience nocturnal urine loss and incontinence (both urinary and fecal), confusion, hallucinations, sleepwalking episodes, or abnormal thinking, you should immediately inform your doctor. Although these effects are rare, if they appear, they are usually mild to moderate in nature.
In elderly people, the doctor will carefully monitor your progress to check if Xyrem is producing the desired effects.
Xyrem has a well-known potential for abuse. There have been cases of dependence after illicit use of sodium oxybate.
Your doctor will ask you if you have used any drugs before starting to take Xyrem and while you are taking this medicine.
Children and adolescents
Xyrem can be taken by adolescents and children from 7 years of age who weigh more than 15 kg.
Xyrem must not be taken by children under 7 years of age or who weigh less than 15 kg.
If you are a child or adolescent, your doctor will regularly check your body weight.
While the doctor is adjusting the dose, which can take several weeks, parents/caregivers must carefully monitor the child's breathing during the first 2 hours after taking sodium oxybate to assess if there is any breathing abnormality; for example, interruption of breathing during short periods while sleeping, noisy breathing, and a bluish color in the lips and face. If breathing abnormalities are observed, medical assistance should be sought and the doctor should be informed as soon as possible. If any abnormality is observed after the first dose, the second dose should not be administered. If no abnormality is observed, the second dose can be administered. The second dose should not be administered before 2.5 hours or after 4 hours after the administration of the first dose.
If you have had or are having unpleasant feelings, especially if you feel very sad or have lost interest in life, it is important that you inform your doctor or caregiver.
Using Xyrem with other medicines
Tell your doctor or pharmacist if you are using, have recently used, or might use any other medicines.
In particular, Xyrem must not be used with medicines that induce sleep and medicines that reduce the activity of the Central Nervous System (the Central Nervous System is the part of the body made up of the brain and spinal cord):
You should also inform your doctor or pharmacist if you are using any of the following types of medicines:
If you are taking valproate, your daily dose of Xyrem will need to be adjusted (see section 3) as it may interact with valproate.
Taking Xyrem with alcohol
Do not drink alcohol while taking Xyrem, as its effects may be increased.
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
There have been very few women who have taken Xyrem during pregnancy, and some of them had miscarriages. The risk of taking Xyrem during pregnancy is not known, so it is not recommended for use in pregnant women or women who are trying to become pregnant.
Patients taking Xyrem must stop breastfeeding, as Xyrem passes into breast milk. Changes in sleep have been observed in breastfed infants of mothers exposed to Xyrem.
Driving and using machines
Xyrem may affect you if you drive or use machines. Do not drive, do not use heavy machinery, or do not perform any activity that may be hazardous or requires mental alertness for at least 6 hours after taking Xyrem. When you first start taking Xyrem and until you know if it makes you sleepy the next day, be extra careful when driving, operating heavy machinery, or doing any other activity that could be dangerous or requires complete mental alertness.
In pediatric patients, doctors, parents, or caregivers are warned that the waiting time for performing activities that require a state of mental alertness, motor coordination, or activities that may have a physical risk may be more than 6 hours, depending on individual sensitivity.
Xyrem contains sodium
This medicine contains 182.24 mg of sodium (the main component of table/cooking salt) per gram. This is equivalent to 9.11% of the maximum recommended daily intake of sodium for an adult.
Consult your doctor or pharmacist if you need to take 2 grams of sodium oxybate (Xyrem) or more per day for a prolonged period, especially if you have been advised to follow a low-salt diet.
Follow the instructions for administration of this medicine exactly as indicated by your doctor or pharmacist. If you are unsure, consult your doctor or pharmacist again.
It is important that you only use the syringe included in the box when preparing Xyrem doses. The Xyrem syringe has two different measurement scales: one scale may be more useful for you than the other, depending on the dose your doctor has prescribed. When looking at each scale, you will see which one has the exact mark for your dose.
Adults: taking Xyrem alone
Adolescents and children from 7 years of age who weigh 15 kg or more: taking Xyrem alone
For children from 7 years of age who weigh 15 kg or more, the doctor will calculate the suitable dose based on body weight.
The doctor will calculate the suitable dose for you. Do not exceed the dose that has been prescribed for you.
Adults: taking Xyrem with valproate
If you are taking valproate with Xyrem, your doctor will adjust your Xyrem dose.
Adolescents and children from 7 years of age who weigh 15 kg or more: taking Xyrem with valproate
If you are taking valproate with Xyrem, your doctor will adjust your Xyrem dose.
Liver or kidney problems
If you have kidney problems, you should follow the dietary recommendations to reduce sodium intake.
If you have liver problems, the initial dose should be reduced by half. Your doctor may gradually increase your dose.
Instructions for diluting Xyrem
The following instructions explain how to prepare Xyrem. Read the instructions carefully and follow them step by step. Do not allow children to prepare Xyrem.
To help you, the Xyrem pack contains 1 bottle of medicine, a graduated syringe (with two different measurement scales), and two dosing cups with child-resistant caps.
Step 1
and unscrew it counterclockwise (to the left).
on a table.
bottle mouth before using it for the first time.
the pressure adapter into the bottle neck. This should only be done the first time the bottle is opened.
The adapter can be left on the bottle for subsequent uses.
Figure 1
Step 2
into the center of the bottle opening and press firmly.
prepare the prescribed dose with the other hand by pulling the plunger.
NOTE: The medicine will not flow into the syringe unless you keep the bottle in a vertical position.
Figure 2
Step 3
Figure 3
Step 4
and turn each cap clockwise (to the right) until it clicks
and is locked in the child-resistant position (caution: as the dosing cup cap is reversible, only after hearing the click sound can you be sure that the cap is securely closed for children).
Figure 4
Just before going to bed:
Then:
If you think that the effect of Xyrem is too strong or too weak, tell your doctor or pharmacist.
If you take more Xyrem than you should
The symptoms of overdose with Xyrem can include agitation, confusion, altered mobility, breathing difficulties, blurred vision, excessive sweating, headache, vomiting, decreased consciousness that can lead to coma, and epileptic seizure, excessive thirst, muscle cramps, and weakness. If you take more Xyrem than you should, or take it by accident, seek immediate emergency medical help. You should take the medicine box with you, even if it is empty.
If you forget to take Xyrem
If you forget to take the first dose, take it as soon as you remember and continue with the procedure described previously. If you miss the second dose, skip that dose and do not take Xyrem again until the next night. Do not take a double dose to make up for the missed doses.
If you are not sure if you have taken Xyrem
In case of doubt about the administration of a dose, do not administer the dose again to reduce the risk of overdose.
If you stop taking Xyrem
You should continue taking Xyrem as long as your doctor prescribes it for you. If the medication is stopped, cataplexy attacks may return, and you may experience insomnia, headache, anxiety, dizziness, sleep disorders, somnolence, hallucinations, and abnormal thinking.
If you stop treatment with Xyrem for more than 14 days, you should consult your doctor, as you may need to restart treatment with Xyrem from a lower dose.
If you have any other questions about the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause adverse effects, although not all people suffer from them. These are often of mild to moderate intensity.
Adults: most frequent adverse effects observed in clinical studies(occurring in 10% to 20% of patients):
If you experience any of these adverse effects, inform your doctor immediately.
Children and adolescents: most frequent adverse effects observed in a clinical study:
If you experience any of these adverse effects, inform your doctor immediately.
The adverse effects in adults and children are the same. If you experience any of these adverse effects, inform your doctor immediately:
Very common (may affect more than 1 in 10 people):
Common (may affect up to 1 in 10 people):
Uncommon (may affect up to 1 in 100 people):
Frequency not known (cannot be estimated from the available data):
If you experience any of these side effects, inform your doctor immediately.
Reporting of Adverse Effects
If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect that is not listed in this leaflet. You can also report them directly through the national reporting system included in Appendix V. By reporting adverse effects, you can contribute to providing more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiration date that appears on the bottle after (EXP). The expiration date is the last day of the month indicated.
After dilution in the dosing cups, the preparation should be used within 24 hours.
Once the Xyrem bottle is opened, any unused content must be discarded after 90 days.
Medicines should not be thrown away through wastewater or household waste. Ask your pharmacist how to dispose of the packaging and medicines that are no longer needed. This will help protect the environment.
Xyrem Composition
Xyrem Composition
Product Appearance and Package Contents
Xyrem is presented in a 240 ml amber plastic bottle containing 180 ml of oral solution, closed with a child-resistant cap. The bottle has a plastic seal layer on the mouth of the bottle, under the cap. Each package contains a bottle, a press-in bottle adapter (PIBA), a graduated plastic syringe, and two dosing cups with child-resistant caps.
Xyrem is a clear to slightly opalescent solution.
Marketing Authorization Holder
UCB Pharma S.A., Allée de la Recherche 60, B-1070 Brussels, Belgium
Manufacturer
UCB Pharma S.A., Chemin du Foriest, B-1420 Braine l'Alleud, Belgium
Your doctor should have given you a package of information about Xyrem, which includes a brochure on how to take the medicine, a patient information leaflet with Frequently Asked Questions, and a patient alert card.
You can request more information about this medicine by contacting the local representative of the marketing authorization holder:
België/Belgique/Belgien UCB Pharma SA/NV Tel/Tél: +32 / (0)2 559 92 00 | Lietuva UCB Pharma Oy Finland Tel: + 358 9 2514 4221 (Suomija) |
Luxembourg/Luxemburg UCB Pharma SA/NV Tél/Tel: +32 / (0)2 559 92 00 | |
Ceská republika UCB s.r.o. Tel: + 420 221 773 411 | Magyarország UCB Magyarország Kft. Tel.: + 36-(1) 391 0060 |
Danmark UCB Nordic A/S Tlf: + 45 / 32 46 24 00 | Malta Pharmasud Ltd. Tel: +356 / 21 37 64 36 |
Deutschland UCB Pharma GmbH Tel: + 49 /(0) 2173 48 4848 | Nederland UCB Pharma B.V. Tel.: +31 / (0)76-573 11 40 |
Eesti UCB Pharma Oy Finland Tel: + 358 9 2514 4221(Soome) | Norge UCB Nordic A/S Tel: +45 / 32 46 24 00 |
Ελλάδα UCB Α.Ε. Τηλ: +30 / 2109974000 | Österreich UCB Pharma GmbH Tel: + 43 (0) 1 291 80 00 |
España UCB Pharma, S.A. Tel: + 34 / 91 570 34 44 | Polska UCB Pharma Sp. z o.o. Tel.: + 48 22 696 99 20 |
France UCB Pharma S.A. Tél: + 33 / (0)1 47 29 44 66 | Portugal UCB Pharma (Produtos Farmacêuticos), Lda Tel: + 351 / 21 302 5300 |
Hrvatska Medis Adria d.o.o. Tel: +385 (0) 1 230 34 46 | România UCB Pharma Romania S.R.L. Tel: +40 21 300 29 04 |
Ireland UCB (Pharma) Ireland Ltd. Tel: + 353 / (0)1-46 37 395 | Slovenija Medis, d.o.o. Tel: + 386 1 589 69 00 |
Ísland Vistor hf. Tel: +354 535 7000 | Slovenská republika UCB s.r.o., organizačná zložka Tel: + 421 (0) 2 5920 2020 |
Italia UCB Pharma S.p.A. Tel: + 39 / 02 300 791 | Suomi/Finland UCB Pharma Oy Finland Puh/ Tel: + 358 9 2514 4221 |
Κύπρος Lifepharma (Z.A.M.) Ltd Τηλ: + 357 22 34 74 40 | Sverige UCB Nordic A/S Tel: + 46 / (0) 40 29 49 00 |
Latvija UCB Pharma Oy Finland Tel: + 358 9 2514 4221(Somija) | United Kingdom(Northern Ireland) UCB (Pharma) Ireland Ltd. Tel: + 353 / (0)1-46 37 395 |
Date of Last Revision of this Leaflet(MM/YYYY)
Other Sources of Information
Detailed information about this medicine is available on the European Medicines Agency website: http://www.ema.europa.eu/